Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy

NCT00850941 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT00850941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00850941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiation Therapy for Rising Prostate Specific Antigen (PSA) Post-prostatectomy
Lead sponsor
M.D. Anderson Cancer Center
Phase
Observational
Overall status
Unknown status
Start date
January 26, 2009
Completion date
January 31, 2021
Enrollment
146 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer